Urology of Virginia

Urology of Virginia has provided comprehensive urological care in Hampton Roads for nearly 100 years. Founded in 1922 by Charles Devine, the practice began growing in the 1950s. The practice gained an international reputation for genitourinary reconstructive surgery, developing new surgical techniques to correct urethral strictures and hypospadias that are still used today. In 1965, Urology of Virginia became one of the few private practices in the country to have a residency program. In the 1970s, we were instrumental in helping establish Eastern Virginia Medical School, Norfolk, Virginia, serving as faculty and becoming one of the first established EVMS departments.

Get in Touch

We are here to help you in anyway. Feel free to click the button below to see contact options.

Contact Us Now!
ESUP Symposium: a multidisciplinary look at the future of bladder cancer treatment - EMUC18

ESUP Symposium: a multidisciplinary look at the future of bladder cancer treatment - EMUC18

A multidisciplinary team of speakers discussed bladder cancer at the ESUP Symposium on Thursday. The Symposium was jointly organized by the EAU Section of Urological Research...

ctDNA Helped Predict Response, Survival After Durvalumab in Lung, Bladder Cancer

ctDNA Helped Predict Response, Survival After Durvalumab in Lung, Bladder Cancer

A decrease in the variant allele frequencies (VAF) of somatic mutations found in circulating tumor DNA (ctDNA) during treatment with durvalumab was associated with improved...

The Perioperative Morbidity of Transurethral Resection of Bladder Tumor

The Perioperative Morbidity of Transurethral Resection of Bladder Tumor

To characterize the perioperative morbidity of transurethral resection of bladder tumor (TURBT) in order to identify important determinants of both quality and cost in the...

 BPH Development, Progression Linked to Sleep Problems

BPH Development, Progression Linked to Sleep Problems

BOSTON—Sleep problems are associated with an elevated the risk of benign prostatic hyperplasia (BPH) development and progression, researchers reported at the American Urological...

Prostatic Urethral Lift an Effective Option for Obstructed Patients

Prostatic Urethral Lift an Effective Option for Obstructed Patients

BOSTON — Minimally invasive prostatic urethral lift (PUL) demonstrates efficacy over 2 years for a majority of transurethral resection of the prostate (TURP) candidates,...

Study: 5-ARIs Do Not Increase PCa Death Risk

Study: 5-ARIs Do Not Increase PCa Death Risk

Previous studies have raised concerns that 5-alpha reductase inhibitors (5-ARIs) might increase the risk of high-grade prostate cancer (PCa), but new research confirms that...

 Preop Foley Catheter Associated With TURP, TULIP Failure

Preop Foley Catheter Associated With TURP, TULIP Failure

HealthDay News — Poor functional status and having a Foley catheter preoperatively are associated with the risk of failure of transurethral resection of the prostate (TURP) or...

Testosterone Therapy May Lower Prostate Cancer Incidence

Testosterone Therapy May Lower Prostate Cancer Incidence

Hypogonadal men who receive testosterone replacement therapy (TRT) may have a lower incidence of prostate cancer (PCa) than those not receiving TRT, according to study findings...

 Auto-Injected Testosterone May Address Some TRT Shortcomings

Auto-Injected Testosterone May Address Some TRT Shortcomings

CHICAGO—Testosterone replacement therapy (TRT) using an auto injector to self-administer testosterone subcutaneously once-weekly maintains testosterone levels in a clinically...

Long-Term Benefit for Stereotactic Radiation in Prostate Cancer

Long-Term Benefit for Stereotactic Radiation in Prostate Cancer

(HealthDay News) -- For men with low- and intermediate-risk prostate cancer (PCa), stereotactic body radiation therapy (SBRT) seems safe and effective in the long term,...

Radiation Ups Survival When PCa Metastatic Burden Is Low

Radiation Ups Survival When PCa Metastatic Burden Is Low

Prostate radiation therapy does not improve overall survival in men with newly diagnosed metastatic prostate cancer (PCa), except for those with a low metastatic burden,...

'Real-World' Study Characterizes PCa Active Surveillance

'Real-World' Study Characterizes PCa Active Surveillance

CHICAGO—Real-world evidence from a large contemporary cohort of men on active surveillance (AS) for prostate cancer (PCa) provides reassurance that disease characteristics are...